We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Dynavax Completes Enrollment for Phase 3 Study of HEPLISAV™

News   Jan 12, 2011

 
Dynavax Completes Enrollment for Phase 3 Study of HEPLISAV™
 
 
 

RELATED ARTICLES

Alzheimer Therapy Proven Safe for Use in Humans in Phase I Trial

News

The Alzheimer drug candidate PRI-002 has successfully completed Phase I of clinical research involving healthy volunteers. When administered daily over a period of four weeks, the active substance proved to be safe for use in humans. The next milestone will be the proof of efficacy in patients in clinical Phase II.

READ MORE

Radiotherapy System Rotates Patients in Sync With X-Ray Beam To Deliver Accurate Treatment for Brain Cancer

News

A new way to deliver radiotherapy that rotates patients in sync with the treatment beam could treat patients with brain cancer as accurately and quickly as the most advanced radiotherapy available, scientists at The Institute of Cancer Research, London show.

READ MORE

Needleless Viral Vaccines Get Helping Hand From Physicists

News

Physicists have delivered virologists a "recipe" for improving vaccine drops using methods from the world of nanophysics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE